Here are relevant reports on : hemophilia-treatment-market
-
Hemophilia Treatment Market by Indication (Type A, Type B), Therapy (Replacement (Recombinant, Plasma Derived), Route of Administration, End User - Global Forecast to 2027
The global hemophilia treatment market is projected to reach USD ~15 billion by 2027 from USD 12 Billion in 2022, at a CAGR of 5% during the forecast period. The major players in the global hemophilia market are Bayer Healthcare (Germany), Octapharma AG (Switzerland), Novo Nordisk (Denmark), Kedrion (Italy), Pfizer Inc. (US), Biogen (US) among others.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Bleeding Disorders Treatment Market by Type (Hemophilia A, Hemophilia B, vWD), Drug Class (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antibrinolytics, Fibrin Sealant) - Global Forecast to 2021
The global bleeding disorders treatment market size is projected to grow at a CAGR of 7.9%. The major factors driving the market growth include the growing patient population base, R&D activities, and increasing focus on recombinant products by pharmaceutical companies. Emerging markets offer significant growth opportunities for the bleeding disorders treatment market.
- Published: July 2016
- Price: $ 4950
- TOC Available:
-
Dual Chamber Prefilled Syringes Market by Material (Glass and Plastic), Indication (Hemophilia, Schizophrenia, Endometriosis, Erectile Dysfunction, and Diabetes), Product (Liquid/Powder, Liquid/Liquid), and Region - Global Forecast to 2025
The Dual Chamber Prefilled Syringes Market is expected to grow from USD 131 million in 2020 to USD 182 million by 2025, at a CAGR of 6.8% during the forecast period. Nipro Corporation (Japan), Gerresheimer AG (Germany), Vetter Pharma (Germany), Credence Medsystems (US), MAEDA INDUSTRY (Japan), and Arte Corporation (Japan) are the key players operating in the Dual Chamber syringes market. Expansions and new product development are the major strategy adopted players to enhance their positions in the Dual Chamber syringes market.
- Published: August 2020
- Price: $ 4950
- TOC Available:
-
Produced Water Treatment Market by Application (Onshore, Offshore), Source (Conventional, Unconventional), Treatment (Primary treatment, Secondary treatment, Tertiary treatment) and Region - Global Forecast to 2029
The produced water treatment market is projected to reach USD 13.4 billion by 2029, at a CAGR of 4.7% during the forecast period. Some of the major players in the produced water treatment market are SLB (US), Baker Hughes Company (US), Siemens Energy (Germany), Veolia Environnement SA (France), TechnipFMC (UK). The major strategies adopted by these players include sales contracts, product launches, investments, collaborations, partnerships, and expansions.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Cold Plasma Market by Application (Plasma Sterilization, Wastewater Treatment, Wound Healing, Surface Treatment, Coating, Packaging, Thin Film Deposition, Etching, Printing, Skin Treatment), by Regime (Low Pressure, Atmospheric) - Global Forecast to 2031
The global cold plasma market is projected to reach USD 3.03 billion by 2031, growing at a CAGR of 7.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Data Center Water & Wastewater Treatment Equipment Market by Data Center Type (Hyperscale, Colocation, Enterprise), by Equipment Type, by Treatment Stage (Pretreatment & Purification, Cooling Water Treatment), and Region - Global Forecast to 2031
The data center water & wastewater treatment equipment market is projected to grow from USD 3.30 billion in 2026 to USD 5.90 billion by 2031, registering a CAGR of 12.3% during the forecast period (2026-2031). To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some top players, such as Veolia (France), Ecolab Inc. (US), Xylem (US), Solenis (US), Saltworks Technologies Inc. (Canada), Aquatech International LLC (US), Kurita America Inc. (US), Gradiant (US), Lenntech B.V. (Netherlands), IDE (Israel)
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Hospital Water Treatment Market by Product (Algaecides, Biocides, Coagulants, Disinfectants, Reverse Osmosis, Nanofiltration, Ultrafiltration), Treatment (Primary, Secondary, Tertiary, Chlorine Disinfection), Source (Laboratories, Laundries, Kitchens, Toilets) - Forecasts to 2022
The global hospital water treatment market is expected to reach USD 7.9 Billion by 2022 from USD 6.0 Billion in 2016, growing at a CAGR of 4.8% from 2016 to 2022. Rising government supports in the hospital waste water management; technological advancements in waste water treatment equipment; increasing government focus on water management; and rising number of hospitals in developing countries are some of the major driving factors driving the growth of global hospital water treatment market.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Industrial Wastewater Treatment Service Market by Service Type (Design, Installation, Operations, Maintenance), Treatment Method (Filtration, Disinfection, Desalination), End User (Power, Oil & Gas, Pulp & Paper), Region - Global Forecast To 2024
The global industrial wastewater treatment service market is projected to reach USD 28.0 billion by 2024 from an estimated USD 20.8 billion in 2019, at a CAGR of 6.1% during the forecast period. This growth can be attributed to factors such as growing government policies and legislative mandates for illegal discharge of wastewater into the environment, need for policy and standards compliance, and need for adhering to the Zero Liquid Discharge (ZLD) initiatives. The major players in the global industrial wastewater treatment service market are Veolia (France). SUEZ (France), Xylem (US), Thermax Group (India). Ecolab (USA), Pentair (UK), Evoqua Water Technologies (USA), WOG Group (USA), SWA Water Holdings (Australia), Aries Chemical (USA), Terrapure Environmental (Canada), and Golder Associates (Canada).
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
Stomach Cancer Treatment Market by Treatment, Type (Chemotherapy, Immunotherapy), Disease Indication (Gastric Cancer), Route of Administration, Drug Class (PD-1/PD-L1 inhibitors, HER2 antagonists), Distribution Channel - Global Forecast to 2027
The global stomach cancer treatment market is projected to reach USD 8 billion by 2027 from USD 4 Billion in 2022, at a CAGR of 14% during the forecast period
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Uterine Fibroid Treatment Devices Market by Technology (Ablation, Hysterectomy, Myomectomy Laparoscopy, Microwave, Cryoablation, HIFU, MRgFUS, Myolysis, Embolization), Mode of Treatment (Invasive, Minimally Invasive, Non-Invasive) - Global Forecasts to 2020
The global uterine fibroid treatment devices market is technologically diverse segment with presence of large number of players. The market offers significant growth opportunities in the next five years to major as well as new players that are aspiring to enter into this medical device segment. Over the past three years, leading players of the global uterine fibroid treatment devices market have adopted new product launches, establishing new manufacturing facilities, and strategic acquisitions as its key business strategies to ensure their positive growth in this market. As of 2014,
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50